Dr Sherry Wu
Dr

Sherry Wu

Email: 
Phone: 
+61 7 336 52785

Availability

Dr Sherry Wu is:
Available for supervision

Qualifications

  • Bachelor (Honours), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Search Professor Sherry Wu’s works on UQ eSpace

65 works between 2009 and 2025
All (65) Journal Article (59) Book Chapter (2) Conference Publication (4)

61 - 65 of 65 works

2011

Journal Article

Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system

Wu, Sherry Y., Chang, Hsin-I, Burgess, Melinda and McMillan, Nigel A. J. (2011). Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system. Journal of Controlled Release, 155 (3), 418-426. doi: 10.1016/j.jconrel.2011.02.002

Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system

2011

Journal Article

Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models

Wu, S. Y., Singhania, A., Burgess, M., Putral, L. N., Kirkpatrick, C., Davies, N. M. and McMillan, N. A. J. (2011). Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models. Gene Therapy, 18 (1), 14-22. doi: 10.1038/gt.2010.113

Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models

2011

Journal Article

Effective delivery of PEGylated siRNA-containing Lipoplexes to extraperitoneal tumours following intraperitoneal administration

Singhania, Akul, Wu, Sherry Y. and McMillan, Nigel A. J. (2011). Effective delivery of PEGylated siRNA-containing Lipoplexes to extraperitoneal tumours following intraperitoneal administration. Journal of Drug Delivery, 2011, 192562.1-192562.7. doi: 10.1155/2011/192562

Effective delivery of PEGylated siRNA-containing Lipoplexes to extraperitoneal tumours following intraperitoneal administration

2009

Journal Article

Lipidic Systems for In Vivo siRNA Delivery

Wu, SY and McMillan, NAJ (2009). Lipidic Systems for In Vivo siRNA Delivery. AAPS JOURNAL, 11 (4), 639-652. doi: 10.1208/s12248-009-9140-1

Lipidic Systems for In Vivo siRNA Delivery

2009

Journal Article

Development of a novel method for formulating stable siRNA-loaded lipid particles for In vivo use

Wu, Sherry Y., Putral, Lisa N., Liang, Mingtao, Chang, Hsin-I, Davies, Nigel M. and McMillan, Nigel A.J. (2009). Development of a novel method for formulating stable siRNA-loaded lipid particles for In vivo use. Pharmaceutical Research, 26 (3), 512-522. doi: 10.1007/s11095-008-9766-1

Development of a novel method for formulating stable siRNA-loaded lipid particles for In vivo use

Current funding

  • 2025 - 2029
    Improving efficacy and reducing side effects of cancer nanomedicines
    NHMRC IDEAS Grants
    Open grant
  • 2023 - 2026
    In vivo genetic engineering of T-cells for cancer treatment using novel exosome mimetic nanoparticles
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2019
    Advanced Nanoparticle, Colloid and Microparticle Characterisation and Precision Engineering Nanosystems Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019 - 2022
    Harnessing the immune system to battle ovarian cancer: A novel approach using naturally occurring exosomes
    NHMRC Project Grant
    Open grant
  • 2019
    Harnessing the immune system to battle ovarian cancer: A novel approach using naturally occurring exosomes
    UQ Foundation Research Excellence Awards
    Open grant
  • 2019
    Vevo 3100 Imaging System for ultrahigh resolution and frame rate echocardiographic assessment of small animals.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2021
    Re-activating anti-tumour immunity by targeting N-MYC-Lec7 axis in ovarian cancer
    Ovarian Cancer Research Foundation
    Open grant
  • 2018
    Re-activating anti-tumour immunity by targeting N-MYC-Lec7 axis in ovarian cancer
    Ovarian Cancer Research Foundation
    Open grant
  • 2018 - 2020
    Re-activating anti-tumor immunity using non-coding RNAs
    Ovarian Cancer Research Foundation Alliance
    Open grant

Availability

Dr Sherry Wu is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Development of a new approach to target exosomes for cancer treatment

    Principal Advisor

    Other advisors: Professor Gregory Monteith

  • Doctor Philosophy

    Developing novel strategies to overcome immune suppression in cancer

    Principal Advisor

  • Doctor Philosophy

    Developing clinically translatable nano-systems to break down immune barriers in cancer

    Principal Advisor

    Other advisors: Associate Professor Peter Moyle

  • Doctor Philosophy

    Developing new strategies to overcome immune suppression in cancer

    Principal Advisor

Completed supervision

Enquiries

For media enquiries about Dr Sherry Wu's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au